Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027627 (metastases)
 103,950 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In 53 p.c. of 175 patients with bronchial carcinoma the carcinoembryonic antigen (CEA) was elevated at the time of diagnosis. In patients with small well bordered tumors (T 1/2) 31 p.c. proved pathological CEA-values in comparison to 80 p.c. in patients with heamatogenic metastases. After radical tumor resection (36 patients) elevated CEA-levels returned to normal ranges within 5 weeks. No decrease could be observed after palliative operations (16 patients). If there existed haematogenic metastases normal CEA-values increased postoperative. Such an increase occured up to ten weeks before metastases could be found by other methods. In cases of bronchial carcinoma CEA-measurements are usefull to evaluate the effect of operation and in the follow up time. It should be carried out on principle in those patients which can be considered for a surgical therapy.
 ...
PMID:[The carcinoembryonic antigen (CEA) in bronchial carcinoma before and after operation (author's transl)]. 7 67

Pharmacokinetic parameters were determined in 18 lung cancer patients after a single administration of 800 mg/24 h of GaCl3: Cmax = 123 +/- 61 mu/l; Tmax = 5.2 +/- 5.5 h; AUCO-96h = 4690 +/- 3358 micrograms.l-1.h; AUCO - infinity = 6394 +/- 5352 micrograms.l-1.h; T 1/2 beta = 43 +/- 19 h. Serum Ga concentrations at the steady-state (Css) were then determined in these patients after a daily oral administration of 800 mg/24 h of GaCl3 for 15 days: Css = 274 +/- 167 micrograms/l. No correlation was found between Css and the previous pharmacokinetic parameters in each patient. Various doses of GaCl3 were administered daily to 45 patients to correlate Css and dosage. Serum Ga concentrations increased with dosage from 100 to 400 mg/24 h (p less than 0.05), but not with further dosages up to 1400 mg/24 h. The optimal daily dose of GaCl3 in lung cancer patients seems to be 400 mg/24 h. In 2 patients, Ga was assayed after death in tissues. Ga concentrations were more than 10 micrograms/g in metastases, 3.6 +/- 2.9 micrograms/g in the primary tumor and 2.3 +/- 0.9 micrograms/g in the kidney. Due to the lack of renal and hematological toxicities and the significant uptake of Ga by the tumor, GaCl3 can be used orally in conjunction with other cytotoxic agents. We intend to evaluate its efficacy according to a randomized study comparing chemotherapy versus chemotherapy plus 400 mg/24 h of GaCl3.
 ...
PMID:Clinical pharmacology of gallium chloride after oral administration in lung cancer patients. 254 82

Intra-arterial hepatic infusion chemotherapy combined with degradable starch microspheres (DSM) and mitomycin C (MMC) was performed for 9 patients with inoperable hepatic metastases from alimentary tract primary cancer. DSM, 45 +/- 5 micron in average diameter, produces temporary obstruction of arterial blood flow in the arterio-capillary bed and are subsequently degraded by serum amylase with T 1/2 of about 30 min. This intra-arterial treatment was repeated 2.3 times on the average. The average dose of DSM in a single infusion was 721 +/- 194 mg and the average total dose of MMC was 34.4 +/- 22.3 mg. Antitumor effects were evaluated in terms of tumor regression measured by CT scan and sonography. An objective tumor response was shown in 4/9 patients (44.4%): PR, 2/9; MR, 2/9. Elevated serum CEA levels of more than 3.0ng/ml were decreased in 7/8 patients (87.5%). Marked declines in the CEA level of more than 50% were observed in 4/8 patients (50%). Nausea and vomiting as well as abdominal pain were experienced in 8/21 treatments (38.1%) and 5/21 (23.8%), respectively. Furthermore, fever (2/21 : 9.5%), hepatic dysfunction (2/21 : 9.5%), and leukopenia (1/21 : 4.8%) were observed. All these side effects, however, were mild and transient. Thus, these results suggest that combined intra-arterial administration of DSM and MMC favorably enhances the antitumor efficacy of MMC.
 ...
PMID:[Combination intra-arterial chemotherapy with degradable starch microspheres and mitomycin C against inoperable hepatic metastases]. 283 18

A 37-year-old woman presented with a neck mass that proved to be medullary thyroid carcinoma by histologic and immunoperoxidase examinations. Serum calcitonin values were greatly elevated (over 100,000 pg/ml). There were widespread metastases in bone and liver. As the peripheral lesions showed only slight response to chemotherapy and local radiation therapy, potential use of radioiodine was studied. The bone lesions showed uptake of both Tc-99m MDP and radioiodide (I-131). Metastatic lesions were similar to the primary tumor in terms of histology, presence of calcitonin, and absence of thyroglobulin. Hence, the patient had a medullary thyroid carcinoma that took up radioiodide in its metastases. Two large oral doses of radioiodide (over 100 mCi each) did not significantly alter the serum calcitonin values, although there was a slight response in the activity of bone lesions. The whole body turnover of radioiodide was rapid (T 1/2 = 0.7 days). Upon oral administration of lithium carbonate, whole-body radioiodide turnover slowed slightly (T 1/2 = 1 day). If this effect were reflected in greater tumor retention of radioiodide (slower release), then agents that block radioiodide egress might have a role to play in therapy.
 ...
PMID:Medullary thyroid carcinoma with radioiodide transport. Effects of iodine-131 therapy and lithium administration. 315 60

The rate of metachronous metastases after curative surgery because of colonic carcinomas was 17% (n = 70). Women (20%) developed metastases more frequently than men (13%). Procedures in third to ninth decennium were followed in decreasing frequency (100 to 8.7%) by metachronous metastases. Primary tumors located in coecum showed by far the strongest tendency to recurrent metastatic disease (29%). Rate of metastases after curative surgery in tumorstage T 1-3 N0M0 was 9%, after stage T4 N0 M0 17% and after resection of tumors with lymph node involvement 32%. Liver metastases arose late when originating from primary in early tumorstage. Survival after diagnosis of liver metastases decreased with extension of primary tumor. These results give some aspects to formation of high-risk-groups to be followed-up according to a special program postoperatively.
 ...
PMID:[Spontaneous course of metachronous metastases following curative intervention for colonic cancer: a total review]. 332 46

We have evaluated the pharmacokinetics in patients of a monoclonal antibody (19-9) F(ab')2 fragment coupled with DTPA and labeled with 111In. In addition to imaging and organ uptake determinations, serum and urine samples were analyzed to help determine the in vivo behavior of the label. Using a competitive binding assay, the immunoreactivity of the coupled fragment was found to be indistinguishable from that of the unmodified fragment. The absence of radiocolloids in the injectate was confirmed as was the in vivo stability of the attached DTPA groups. By a variety of techniques, we show that the only significant source of label instability was transcomplexation to circulating transferrin. About 9% per day of label exposed to transferrin (about 1-2% of the injected dose) dissociated with slight bone marrow accumulation. Following i.v. administration, serum activity levels fell rapidly (T 1/2 alpha 2 hr, T 1/2 beta 19 hr). Whole-body clearance of the label was slow (T 1/2 160 hr) and may be attributed entirely to urinary excretion (0.26% of the injected dose per hour). Organ accumulation was greatest in the liver and persisted after rapidly attaining high values (20% of the injected dose). A total of 14 cancer patients were studied, nine with identifiable sites of metastatic disease from colorectal [8], pancreatic [2], ovarian [3], or small cell lung [1] primaries. Eight of the 12 sites of documented tumor were visualized by external imaging (67%) most distinctly at 48-72 hr postadministration.
 ...
PMID:Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients. 386 93

A total of 82 histologically proven squamous cell carcinomas of the tongue, which were treated by interstitial irradiation (radium) at Chiba Cancer Center from 1973-1982, were reviewed. The cumulative five-year survival rate of all cases was 64%: 78% in Stage I and II group, 68% in Stage III and 47% in Stage IV. Local recurrence was noted in eight cases (10%) and later cervical node metastases in 14 cases 25% in T 1-4 N 0). The incidence of mandibular osteoradionecrosis was 18 cases (22%).
 ...
PMID:[Radiotherapy (interstitial irradiation) of carcinoma of the tongue--an analysis of cases in the past 10 years]. 408 82

Therapeutic results in 287 glottic and subglottic carcinomas stage I-IV are reported. After primary irradiation and salvage surgery of recurrences the actuarial 10 year-NED probability for tumours with normal mobility of the vocal cords was 78%, for those with impaired mobility it was 60% and for tumours with complete fixation in stage III it was only 27%. The relative actuarial 10 year-survival probability of the same groups were 96%, 82% and 35%. Salvage surgery was performed in 48/51 patients (94%) with radioresistent tumours or recurrences and was successful in 37/48 (77%) of the patients. The larynx could be saved in 162/210 (77%) curative irradiated patients. Primary irradiation can be recommended as the method of choice in glottic carcinoma T 1 + 2. It can be proved also in T3-tumours as alternative to preoperative irradiation and laryngectomy if adequate follow-up is possible, otherwise combined preoperative irradiation and laryngectomy is preferred. Dose levels equivocal to CRE 19 are recommended for curative irradiation of T 1 + 2 N0-tumours. For more advanced tumours T3 + 4 and cervical metastases greater than 3 cm about 10% higher doses are needed. Different fractionation schedules for curative and preoperative irradiation are discussed. A highly significant dose-effect relation was found for dose levels above and below CRE 18.
 ...
PMID:[Radiotherapy of cancer of the vocal cords. Report on 287 patients]. 646 26

The prognostic significance of 2 histological parameters, the level of invasion and maximum thickness is evaluated in 248 cases of malignant melanoma of the limbs staged T 1-3 N0M0 which were collected for Trial No. 1 of the W.H.O. Collaborating Centres for the Evaluation of Methods of Diagnosis and Treatment of Melanoma between September 1967 and December 1974. There is a linear relation of tumor thickness to mortality with a high statistical significance (P = 0.0002). Mortality also increases with progression of the level of invasion. The incidence of occult metastases to the regional lymph nodes increases with increasing thickness or level of invasion. Moreover, the age and sex adjusted survival curves are also dependent on both parameters. The comparison of the two methods revealed that the maximal tumor thickness is a more reliable prognostic factor than is the determination of the level of invasion.
 ...
PMID:[1st Stage I melanoma of the limbs. Prognosis on the basis of the depth of invasion and maximum thickness]. 745 19

As well as radical prostatectomy external body radiotherapy (EBRT) offers the chance of cure in non-metastasized prostate cancer. With total doses of 70 Gy or more, conventional fractionated RT can achieve 2-years biological no-evidence of disease (bNED) of more than 90% and about 50% in tumor stages with low and medium risk of metastases respectively. In early stages (T 1-2 Nx) recurrence free survival is after ten years 43-76%, in T1b-T2 pNO stages it is about 90% and comparable to those after radical prostatectomy. In T3-tumors recurrence free survival is from 32-42%. In randomized studies an advantage of conformal to conventional planned EBRT could be impressively demonstrated. Severe sequelae of the intestinal and urogenital tract could be seen in less than 5%, of treated patients. The value of combined hormonal and radiation therapy is not yet cleared. In early stages results by pure EBRT are convincing so that hormonal therapy might be superfluous. In locally advanced stages a preceding hormonal therapy might decrease the tumor volume by reducing the tumor cell load and, therefore, reduce the conformally irradiated volume. The irradiation of the pelvic or abdominal lymphatic drainage did not improve overall survival in published studies so far though improving the locoregional tumor control rates. Due to the large irradiated volume and simple radiation techniques sequelae were impressively increased. A participation in running national or international studies to clarify the value of postoperative EBRT, RT of pelvic lymph nodes, dose escalation and combined hormonal and radiation therapy will be reasonable.
 ...
PMID:[Radiotherapy of prostate carcinoma]. 1167 16


1 2 Next >>